Akebia Therapeutics, Inc. (AKBA)
0.9626
+0.02
(+1.70%)
USD |
NASDAQ |
Sep 11, 15:41
Akebia Therapeutics Gross Profit (TTM) : 172.88M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 172.88M |
| March 31, 2026 | 186.99M |
| December 31, 2025 | 195.46M |
| September 30, 2025 | 172.30M |
| June 30, 2025 | 146.14M |
| March 31, 2025 | 120.10M |
| December 31, 2024 | 91.34M |
| September 30, 2024 | 106.88M |
| June 30, 2024 | 107.62M |
| March 31, 2024 | 120.11M |
| December 31, 2023 | 118.89M |
| September 30, 2023 | 81.75M |
| June 30, 2023 | 68.13M |
| March 31, 2023 | 136.79M |
| December 31, 2022 | 147.31M |
| September 30, 2022 | 156.92M |
| June 30, 2022 | 185.23M |
| March 31, 2022 | 77.80M |
| December 31, 2021 | 65.05M |
| September 30, 2021 | 48.39M |
| June 30, 2021 | 39.18M |
| March 31, 2021 | 69.80M |
| December 31, 2020 | 112.85M |
| September 30, 2020 | 151.28M |
| June 30, 2020 | 175.86M |
| Date | Value |
|---|---|
| March 31, 2020 | 209.77M |
| December 31, 2019 | 190.50M |
| September 30, 2019 | 211.02M |
| June 30, 2019 | 157.31M |
| March 31, 2019 | 92.87M |
| December 31, 2018 | 51.90M |
| September 30, 2018 | 90.36M |
| June 30, 2018 | 90.36M |
| March 31, 2018 | 90.36M |
| December 31, 2017 | 90.36M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | -0.094M |
| March 31, 2017 | -0.14M |
| December 31, 2016 | -0.172M |
| September 30, 2016 | -0.183M |
| June 30, 2016 | -0.124M |
| March 31, 2016 | -0.11M |
| December 31, 2015 | -0.0967M |
| September 30, 2015 | -0.1014M |
| June 30, 2015 | -0.0796M |
| March 31, 2015 | -0.0596M |
| December 31, 2014 | -0.049M |
| September 30, 2014 | -0.0345M |
| June 30, 2014 | -0.0213M |
| March 31, 2014 | -0.0094M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Emergent BioSolutions, Inc. | 363.30M |
| Exelixis, Inc. | 2.350B |
| ADMA Biologics, Inc. | 331.27M |
| Arcutis Biotherapeutics, Inc. | 422.88M |
| Relay Therapeutics, Inc. | 8.139M |